January 04, 2010
Gilead Sciences to Present at Two Upcoming Investor Conferences
John C. Martin, PhD, Gilead's Chairman and Chief Executive Officer, will provide an overview of the company at the Goldman Sachs conference on Wednesday, January 6 at 11:00 a.m. Eastern Standard Time (EST) and the J.P. Morgan conference on Monday, January 11 at 9:30 a.m. Pacific Standard Time (12:30 p.m. EST).
To access the live webcasts via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
SOURCE: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)